Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Incannex Healthcare Inc. - Common Stock
(NQ:
IXHL
)
1.760
-0.010 (-0.56%)
Streaming Delayed Price
Updated: 3:59 PM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Incannex Healthcare Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
8
Next >
Bearish Monday For Marijuana Stocks - EVIO, Item 9 Labs Among Top Gainers
August 07, 2023
Via
Benzinga
Psyched: Portugal Decriminalizes Synthetic Drugs, Anorexia And Psilocybin, LSD Microdosing, California & More
August 03, 2023
A Revolutionary Approach: Portugal Decriminalizes Synthetic Drugs Portugal’s Parliament recently decriminalized the use of synthetic drugs. The new law equates the legal treatment of these substances...
Via
Benzinga
Incannex Healthcare: Is Life Better On Nasdaq?
July 24, 2023
Incannex Healthcare is planning to redomicile to the US in a move designed to access deeper pools of capital and increase the company’s long-term market valuation. We interview the CEO of the...
Via
Talk Markets
Cannabis Stock Gainers And Losers From August 4, 2023
August 04, 2023
Via
Benzinga
July Summary: Largest Psychedelic Compound-Based R&D Stocks Up 16%, On Average
July 30, 2023
All but 1 of the 6 largest psychedelic compound-based research & development stocks advanced in July and are ranked below as to their performances so far in July:
Via
Talk Markets
Small Pharma's Q1 2024: Revamping Strategy And Potential Fast-Tracked Clinical Trial
July 28, 2023
UK’s short-acting psychedelics developer Small Pharma (OTCQB: DMTTF) published its financial results for the fiscal first quarter ended May 31, 2023:
Via
Benzinga
Cannabis Stock Movers For August 3, 2023
August 03, 2023
Via
Benzinga
Incannex thrilled with positive pre-IND meeting for arthritis treatment
July 27, 2023
Incannex Healthcare Ltd (ASX:IHL, NASDAQ:IXHL) chief scientific officer Dr Mark Bleackley tells Proactive the company has completed a constructive pre-Investigational New Drug (IND) application meeting...
Via
TheNewswire.com
Exposures
Product Safety
Incannex thrilled with positive pre-IND meeting for arthritis treatment
July 27, 2023
--News Direct--
Via
News Direct
Exposures
Product Safety
Marijuana Stock Movers For August 2, 2023
August 02, 2023
Via
Benzinga
Incannex Completes Positive Pre-IND Meeting With FDA On CBD-Based Drug For Treatment Of Rheumatoid Arthritis
July 26, 2023
Incannex Healthcare Limited (NASDAQ: IXHL) (ASX:IHL) has completed a constructive pre-Investigational New Drug Application (‘pre-IND’) meeting with the U.S.
Via
Benzinga
Largest Psychedelic Compound-Based Drug Stocks Up 14% MTD; Now Up 27% YTD
July 23, 2023
The psychedelic compound-based drug research and development sector is UP 13.6% MTD and is now UP 26.6% YTD and this article analyzes the performance of the 6 largest stocks in the Psychedelic Drug...
Via
Talk Markets
Marijuana Stock Movers For August 1, 2023
August 01, 2023
Via
Benzinga
Incannex Submits IND Application To The FDA For Dronabinol-Based Drug For Obstructive Sleep Apnea
July 21, 2023
Incannex Healthcare Limited (NASDAQ: IXHL) (ASX:IHL) has successfully submitted an Investigational New Drug (‘IND’) application to the US Food and Drug Administration for IHL-42X for treatment of...
Via
Benzinga
Incannex appoints CRO ahead of Phase 2/3 sleep apnoea trial
July 18, 2023
Incannex Healthcare Ltd (ASX:IHL, NASDAQ:IXHL) CEO Joel Latham tells Proactive the company has engaged Fortrea as the contract research organisation (CRO) to manage the IND opening Phase 2/3 clinical...
Via
TheNewswire.com
Cannabis Stock Gainers And Losers From July 28, 2023
July 28, 2023
Via
Benzinga
Incannex appoints CRO ahead of Phase 2/3 sleep apnoea trial
July 18, 2023
--News Direct--
Via
News Direct
Cannabis Stock Gainers And Losers From July 26, 2023
July 26, 2023
Via
Benzinga
Fortrea To Manage Incannex's FDA IND Opening Phase 2/3 Trial Of Its Dronabinol-Based Drug For Obstructive Sleep Apnea
July 18, 2023
Incannex Healthcare Limited (NASDAQ: IXHL) (ASX: IHL) has engaged Fortrea (NASDAQ: FTRE) as the contract research organisation for management of the IND opening p
Via
Benzinga
Psychedelic Compound-Based Drug Stocks Up 12% MTD; Now Up 25% YTD
July 14, 2023
Our Psychedelic Drug Stocks Index is up 12.3% MTD and is now up 25.1% YTD.
Via
Talk Markets
Cannabis Stock Movers For July 19, 2023
July 19, 2023
Via
Benzinga
Incannex Receives HREC Approval For Phase 2 Clinical Trial Of CBD-Based Drug For Use In Treatment Of Rheumatoid Arthritis
July 13, 2023
Incannex Healthcare Limited (NASDAQ: IXHL) (ASX:IHL) has received approval from Bellberry Human Research Ethics Committee (‘HREC’) for the lead site, Emeritus Research, Camberwell, Victoria, for its...
Via
Benzinga
Incannex CEO talks plans to redomicile to US
July 11, 2023
Incannex Healthcare Ltd (ASX:IHL, NASDAQ:IXHL) CEO Joel Latham tells Proactive the company has begun the process of shifting all outstanding shares to the Nasdaq after making the decision to redomicile...
Via
TheNewswire.com
Incannex CEO talks plans to redomicile to US
July 11, 2023
Incannex CEO talks plans to redomicile to US
Via
News Direct
Incannex To Redomicile To United States, List All Shares On Nasdaq
July 10, 2023
Incannex Healthcare Limited (NASDAQ: IXHL) (ASX:IHL) intends to redomicile from Australia to the United States via proposed schemes of arrangement between Incannex and its shareholders (share scheme)...
Via
Benzinga
Psychedelic Stocks Jumped 10% Last Week
July 09, 2023
The FDA released a positive draft guidance for developing psychedelic treatments and the 6 largest stocks in the Psychedelic Drug Stocks Index responded accordingly
Via
Talk Markets
12 Health Care Stocks Moving In Friday's Intraday Session
July 07, 2023
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
July 07, 2023
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
July 06, 2023
Via
Benzinga
Incannex Approved For Bioavailability Clinical Trial For Dronabinol-Based Drug For Treatment Of Obstructive Sleep Apnea
July 06, 2023
Incannex Healthcare Limited (NASDAQ: IXHL) (ASX:IHL) has received approval from Bellberry Human Research Ethics Committee to commence a bioavailability/bioequivalence (‘BA/BE’) clinical trial on...
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.